New and Improved Disease Analysis Reports

The Report Store would like to introduce our newest Disease Analysis report enhancements based on your feedback and suggestions about our previous reports template. Disease Analysis (formerly Core Disease) reports additions include: Recent Events & Analyst Opinion; Consensus Forecasts; Probability of Success; and more.

Are you ready to experience the new reports interface? New enhancements include:

  • Highlighted high value content and analyst expertise
  • New, streamlined templates will highlight the expert analysis you’re accustomed to
  • Simplified navigation
  • Quick and easy access to high value analysis with significantly reduced duplication
  • More coverage than ever before
  • Disease Analysis reports additions include: Recent Events & Analyst Opinion; Consensus Forecasts; Probability of Success; and more. Company report additions include: Earnings Reviews; Key Management Quotes; Forecasts; and Opinions & Analysis
  • Additional hot topics coverage
  • Updated interface improves time spent covering hot topics and producing one-off pieces of content
  • Find relevant content faster than ever before
  • Find, get to and get through the information that matters to you

Related Reports

Hepatitis C

Datamonitor Healthcare estimates that in 2018, there were 72.2 million prevalent cases of hepatitis C worldwide.

Overview

Triple-negative breast cancer (TNBC) is characterized by the absence of estrogen and progesterone receptors, and does not involve the overexpression of human epidermal growth factor 2 (HER2). Datamonitor Healthcare estimates that in 2018 there were 2.1 million incident cases and 8.6 million five-year prevalent cases of breast cancer worldwide. By 2027, incident and prevalent cases of breast cancer are expected to increase to 2.3 million and 9.3 million cases, respectively.

Datamonitor Healthcare estimates that in 2018, there were 74.5 million prevalent cases of Alzheimer’s disease in adults aged 65 years and older worldwide, and forecasts that number to increase to 102.5 million prevalent cases by 2027.

Osteoporosis

Datamonitor Healthcare estimates that in 2018, there were 345.8 million prevalent cases of osteoporosis among adults aged 50 years and older worldwide, and forecasts that number to increase to 427.8 million prevalent cases by 2027.

Datamonitor Healthcare estimates that in 2018 there were approximately 1.5 billion prevalent cases of dyslipidemia in adults aged 20 years and older worldwide, and forecasts that number to increase to 1.7 billion prevalent cases by 2027.